Volume 3, issue 3, June 2011

6 articles in this issue

Analyzing the impact of 23 mg/day donepezil on language dysfunction in moderate to severe Alzheimer's disease

Authors (first, second and last of 7)
- Steven H Ferris
- Frederick A Schmitt
- Yikang Xu
- Content type: Research
- Open Access
- Published: 20 June 2011
- Article: 22
Mitochondrial therapeutics in Alzheimer's disease and Parkinson's disease

Authors (first, second and last of 4)
- Jake G Hoekstra
- Kathleen S Montine
- Thomas J Montine
- Content type: Review
- Published: 29 June 2011
- Article: 21
The β-secretase enzyme BACE1 as a therapeutic target for Alzheimer's disease

Authors
- Robert Vassar
- Patty C Kandalepas
- Content type: Review
- Published: 31 May 2011
- Article: 20
Should persons with autosomal dominant AD be included in clinical trials? Authors' response

Authors
- Kinga Szigeti
- Rachelle S Doody
- Content type: Letter
- Published: 23 May 2011
- Article: 19
Should persons with autosomal dominant AD be included in clinical trials?

Authors
- Joshua D Grill
- John M Ringman
- Content type: Letter
- Published: 23 May 2011
- Article: 18
Right sizing funding for Alzheimer's disease

Authors
- Todd E Golde
- Bruce T Lamb
- Douglas Galasko
- Content type: Editorial
- Published: 06 May 2011
- Article: 17